Filing Details
- Accession Number:
- 0001237899-19-000025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-26 16:29:50
- Reporting Period:
- 2019-11-25
- Accepted Time:
- 2019-11-26 16:29:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226689 | Neil Stahl | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Research And Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-25 | 10,000 | $52.03 | 32,455 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-25 | 5,994 | $362.75 | 26,461 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2019-11-26 | 1,422 | $363.58 | 25,039 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 2,284 | $364.20 | 22,755 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 300 | $365.41 | 22,455 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-11-25 | 10,000 | $0.00 | 10,000 | $52.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 88,079 | 2021-12-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,736 | Indirect | By 401(k) Plan |
| Common Stock | 7,831 | Indirect | by 2018 GRAT |
Footnotes
- Represents volume-weighted average price of sales of 1,422 shares of Company stock on November 26, 2019 at prices ranging from $363.07 to $363.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2019 at each separate price.
- Represents volume-weighted average price of sales of 2,284 shares of Company stock on November 26, 2019 at prices ranging from $364.00 to $364.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2019 at each separate price.
- Represents volume-weighted average price of sales of 300 shares of Company stock on November 26, 2019 at prices ranging from $365.26 to $365.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2019 at each separate price.
- With respect to 75,000 underlying shares, the option became exercisable on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014. With respect to 48,079 underlying shares (of which 13,079 remain outstanding), the stock option award vested in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
